TTE_PVV_1_36: Evaluation in 15 Participants of Blood Flow, Comfort and Efficiency, Using 1 vs 36 Hz Stimulation Via Textile Electrodes

Sponsor
Karolinska University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT06082297
Collaborator
(none)
15
1
1
27
16.9

Study Details

Study Description

Brief Summary

Muscle contractions induced by calf low-intensity neuromuscular electrical stimulation (C-LI-NMES) can increase venous return and may reduce venous thromboembolism. This study aimed to compare the effect of different C-LI-NMES frequencies and plateau times on hemodynamics, discomfort and energy efficiency, when applied via sock-integrated transverse textile electrodes.

Condition or Disease Intervention/Treatment Phase
  • Device: Chattanooga Physio, DJO, neuromuscular electrical stimulation
N/A

Detailed Description

Fifteen healthy participants were stimulated via two 3x3cm transverse textile electrodes integrated in a sock, with ten different combinations of frequency (1Hz or 36Hz) and plateau times (0.5/1.5/3/5/7s), with gradually increasing NMES-intensity until plantar flexion-induction. At this point, popliteal peak venous velocity (PVV), time-averaged mean velocity (TAMV) and ejection volume (EV) were assessed by Doppler-ultrasound, discomfort by a numerical rating scale (NRS, 0-10) and values for current amplitude and energy were calculated based on the NMES-deviceĀ“s intensity level. Values expressed with median (interquartile range), significance set to p<0.05.

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
N/A
Intervention Model:
Sequential Assignment
Intervention Model Description:
Repeated measures tests on on each of the 15 participants, comparing outcomes for no intervention and 10 different interventions in the form of variations in parameter-settings of neuromuscular electrical stimulation, with gradually increasing current amplitude until induction of ankle plantar flexion.Repeated measures tests on on each of the 15 participants, comparing outcomes for no intervention and 10 different interventions in the form of variations in parameter-settings of neuromuscular electrical stimulation, with gradually increasing current amplitude until induction of ankle plantar flexion.
Masking:
None (Open Label)
Masking Description:
Participants did not receive information about what parameter-settings that were used for the different tests.
Primary Purpose:
Basic Science
Official Title:
Can Blood Flow Enhancing Plantar Flexion Electrically Induced Via Textile Electrodes in a Sock Using 1 Hz Frequency Give Better Comfort and Energy Efficiency as Compared to 36 Hz ?
Actual Study Start Date :
Jul 17, 2019
Actual Primary Completion Date :
Aug 13, 2019
Actual Study Completion Date :
Aug 13, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Single arm where repeated measures where performed in 15 participants.

Each of the 15 participants in the arm was, in addition to the resting state (no intervention), exposed to 10 different interventions repeated after each other to enable repeated measures of the outcomes.

Device: Chattanooga Physio, DJO, neuromuscular electrical stimulation
Neuromuscular electrical stimulation (NMES) was applied with a device called Chattanooga Physio (DJO), testing 10 different combinations of parameter-settings. The parameter-settings that were varied and combined were frequency (1Hz and 36Hz) and plateau times (0.5s, 1.5s, 3s, 5s, 7s). The NMES was applied to the calf of the participants via transversally placed textile electrodes (3x3 cm) integrated in a sock starting with very low current amplitude followed by gradual small increases in current amplitude until induction of ankle plantar flexion, at which time-point the outcomes where measured.
Other Names:
  • Device name and manufacturer:
  • Outcome Measures

    Primary Outcome Measures

    1. Peak venous velocity (PVV) [Day 1 at rest (baseline, no intervention) and when ankle plantar flexion was induced by the intervention]

      Peak venous velocity (centimeters per second) will be assesed by Doppler ultrasound of in the popliteal vein

    2. Time averaged mean velocity (TAMV) [Day 1 at rest (baseline, no intervention) and when ankle plantar flexion was induced by the intervention]

      Time averaged mean velocity will be assesed by Doppler ultrasound in the popliteal vein (centimeters per second)

    3. Average duration of blood pulse (ADBP) [Day 1 at rest (baseline, no intervention) and when ankle plantar flexion was induced by the intervention]

      Average duration of blood pulse will be assesed by Doppler ultrasound in the popliteal vein (seconds)

    4. Ejection volume (EV) [Day 1 at rest (baseline, no intervention) and when ankle plantar flexion was induced by the intervention]

      Ejection volume of blood will be assesed by Doppler ultrasound in the popliteal vein (milliliters)

    Secondary Outcome Measures

    1. Numerical rating scale (NRS) [Day 1 during ankle plantar flexion was induced by the intervention]

      Discomfort estimated using a numerical rating scale from 0 (no pain) to 10 (worst pain)

    2. Current amplitude [Day 1 during ankle plantar flexion was induced by the intervention]

      Current amplitude in milliampere (mA) will be assessed by using stepwise increases (typically 1mA) on the NMES device until a plantar flexion is induced

    3. Energy [Day 1 during ankle plantar flexion was induced by the intervention]

      Energy per stimulation cycle in millijoule (mJ) will be assessed by using stepwise increases (typically 1mA) on the NMES device until a plantar flexion is induced, at which point the energy consumption (mJ) is calculated.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 99 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Age 18-99 years of age

    • Voluntary participation

    Exclusion Criteria:
    • Pregnancy

    • Pacemaker

    • Ongoing thromboprophylaxis

    • Skin wounds

    • Vascular abnormalities

    • Previous vascular system surgery in the lower limbs

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Karolinska university Hospital Stockholm Sweden 17176

    Sponsors and Collaborators

    • Karolinska University Hospital

    Investigators

    • Principal Investigator: Paul Ackermann, PhD, MD, Karolinska Institutet

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Paul Ackermann, Professor,MD,PhD, Karolinska University Hospital
    ClinicalTrials.gov Identifier:
    NCT06082297
    Other Study ID Numbers:
    • TTE_PVV_1_vs_36_Hz
    First Posted:
    Oct 13, 2023
    Last Update Posted:
    Oct 13, 2023
    Last Verified:
    Oct 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Paul Ackermann, Professor,MD,PhD, Karolinska University Hospital

    Study Results

    No Results Posted as of Oct 13, 2023